123 related articles for article (PubMed ID: 37801909)
1. Clinicopathological significance and the associated signaling pathway of p21-activated kinase 1 (PAK1) in colorectal cancer.
Pyo JS; Min KW; Oh IH; Lim DH; Son BK
Pathol Res Pract; 2023 Nov; 251():154820. PubMed ID: 37801909
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological significance of expression and amplification of P21-activated kinase 1 gene in colorectal carcinoma].
Li ZX; Zeng SD; Liu YD; Liao YJ; Hua WF; Lin F; Xie D
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):185-8. PubMed ID: 19296259
[TBL] [Abstract][Full Text] [Related]
3. Disheveled-associated activator of morphogenesis 2 promotes invasion of colorectal cancer by activating PAK1 and promoting MMP7 expression.
Chen A; Liu Z; Wu Q; Li H
Genes Genomics; 2021 Aug; 43(8):923-935. PubMed ID: 33974241
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of PD-L1 expression in colorectal cancer: Impact of PD-L1 expression on pFOXO1 expression.
Pyo JS; Ko SH; Ko YS; Kim NY
Pathol Res Pract; 2020 Feb; 216(2):152764. PubMed ID: 31836325
[TBL] [Abstract][Full Text] [Related]
5. P21-activated kinase 1 promotes colorectal cancer survival by up-regulation of hypoxia-inducible factor-1α.
Liu KH; Huynh N; Patel O; Shulkes A; Baldwin G; He H
Cancer Lett; 2013 Oct; 340(1):22-9. PubMed ID: 23811286
[TBL] [Abstract][Full Text] [Related]
6. P21-activated kinase 1 and 4 were associated with colorectal cancer metastasis and infiltration.
Song B; Wang W; Zheng Y; Yang J; Xu Z
J Surg Res; 2015 Jun; 196(1):130-5. PubMed ID: 25791829
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance and angiogenic role of the constitutive phosphorylation of the FOXO1 transcription factor in colorectal cancer.
Ko YS; Kim NY; Pyo JS
Pathol Res Pract; 2020 Nov; 216(11):153150. PubMed ID: 32829108
[TBL] [Abstract][Full Text] [Related]
8. TPL2 expression is correlated with distant metastasis and poor prognosis in colorectal cancer.
Pyo JS; Park MJ; Kim CN
Hum Pathol; 2018 Sep; 79():50-56. PubMed ID: 29763718
[TBL] [Abstract][Full Text] [Related]
9. Glaucarubinone inhibits colorectal cancer growth by suppression of hypoxia-inducible factor 1α and β-catenin via a p-21 activated kinase 1-dependent pathway.
Huynh N; Beutler JA; Shulkes A; Baldwin GS; He H
Biochim Biophys Acta; 2015 Jan; 1853(1):157-65. PubMed ID: 25409929
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance and prognostic implication of nuclear fatty acid-binding protein 4 expression in colorectal cancer.
Kim SH; Pyo JS; Son BK; Oh IH; Min KW
Pathol Res Pract; 2023 Sep; 249():154722. PubMed ID: 37591068
[TBL] [Abstract][Full Text] [Related]
11. Expression of P21-activated kinase 1 and cell division control protein 42 homolog correlates with clinicopathological features and prognosis in cervical carcinoma.
Feng Y; Fang S; Li M
J Obstet Gynaecol Res; 2016 Jul; 42(7):860-9. PubMed ID: 27060895
[TBL] [Abstract][Full Text] [Related]
12. Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade.
Chen Y; Peng Y; Yu J; Chen T; Wu Y; Shi L; Li Q; Wu J; Fu X
Oncotarget; 2017 May; 8(19):31802-31814. PubMed ID: 28423670
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of p21-activated protein kinase 1 correlates with poor histological differentiation in pancreatic cancer.
Han J; Wang F; Yuan SQ; Guo Y; Zeng ZL; Li LR; Yang J; Wang DS; Liu MY; Zhao H; Liu KY; Liao JW; Zou QF; Xu RH
BMC Cancer; 2014 Sep; 14():650. PubMed ID: 25182632
[TBL] [Abstract][Full Text] [Related]
14. Correlations of P21-activated kinase 1 expression to clinicopathological features of gastric carcinoma and patients' prognosis.
Wang JX; Zhou YN; Zou SJ; Ren TW; Zhang ZY
Chin J Cancer; 2010 Jul; 29(7):649-54. PubMed ID: 20591216
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer.
Huynh N; Shulkes A; Baldwin G; He H
Cancer Biol Ther; 2016 Aug; 17(8):813-23. PubMed ID: 27260988
[TBL] [Abstract][Full Text] [Related]
16. PAK1-dependent MAPK pathway activation is required for colorectal cancer cell proliferation.
Qing H; Gong W; Che Y; Wang X; Peng L; Liang Y; Wang W; Deng Q; Zhang H; Jiang B
Tumour Biol; 2012 Aug; 33(4):985-94. PubMed ID: 22252525
[TBL] [Abstract][Full Text] [Related]
17. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
18. Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer.
Kamai T; Shirataki H; Nakanishi K; Furuya N; Kambara T; Abe H; Oyama T; Yoshida K
BMC Cancer; 2010 Apr; 10():164. PubMed ID: 20426825
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway.
Wang Z; Jia G; Li Y; Liu J; Luo J; Zhang J; Xu G; Chen G
Oncotarget; 2017 Apr; 8(14):22563-22580. PubMed ID: 28186966
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer.
Khare V; Dammann K; Asboth M; Krnjic A; Jambrich M; Gasche C
Inflamm Bowel Dis; 2015 Feb; 21(2):287-96. PubMed ID: 25569743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
